- Report
- August 2023
- 110 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- July 2023
- 145 Pages
Global
From €2995EUR$3,150USD£2,516GBP
- Report
- July 2023
- 355 Pages
Global
From €3422EUR$3,600USD£2,875GBP
- Report
- December 2023
- 158 Pages
Global
€4749EUR$4,995USD£3,989GBP
- Report
- August 2023
- 115 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- June 2023
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Book
- January 2025
- 496 Pages
- Book
- February 2023
- 576 Pages
- Book
- December 2021
- 576 Pages
- Book
- February 2021
- 512 Pages
- Book
- March 2013
- 536 Pages

The Novel Drug Delivery System market is a subset of the larger Drug Delivery market. It focuses on the development and commercialization of new drug delivery systems, such as nanotechnology, gene therapy, and targeted drug delivery. These systems are designed to improve the efficacy of drugs, reduce side effects, and increase patient compliance. Novel Drug Delivery Systems are used to deliver drugs to specific sites in the body, such as the lungs, brain, and skin. They can also be used to deliver drugs to specific cells or tissues.
The Novel Drug Delivery System market is driven by the increasing demand for more effective and safer drug delivery systems. This is due to the rising prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular diseases. Additionally, the increasing focus on personalized medicine and the development of new technologies are expected to drive the market growth.
Some of the major companies in the Novel Drug Delivery System market include Pfizer, Merck, Novartis, Johnson & Johnson, and Sanofi. Show Less Read more